Southpoint Capital Advisors LP's Form 4 filing
Fennec Pharmaceuticals Inc.FENC · filed Dec 29, 2025
- Accession no.
- 0001012975-25-000985
- Filed
- Dec 29, 2025, 4:34 PM ET
- Trade date
- Dec 24, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $7.50M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Southpoint Capital Advisors LPCIK 0001319998 | 10% Owner |
| Southpoint GP, LPCIK 0001378376 | 10% Owner |
| Southpoint Capital Advisors LLCCIK 0001378377 | 10% Owner |
| Southpoint GP, LLCCIK 0001378378 | 10% Owner |
| Clark John Smith IICIK 0001378379 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | Common Stock | SSaleDisposed | −1,000,000 | $7.50 | −$7,500,000 | 2,744,741 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.